Aggredyne pulls in $3M in latest financing round

04/24/2012 | American City Business Journals

Aggredyne, a biomedical diagnostics firm involved in platelet function testing, raised $3 million in a Series A convertible preferred stock funding round. The Houston firm is preparing to apply for U.S. marketing approval for its laser-light scattering platelet aggregometer, AggreGuideTM A-100, and related blood platelet tests.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA